Utility of the Rapid B-Type Natriuretic Peptide Assay for Detection of Cardiovascular Problems in Newborn Infants with Respiratory Difficulties
Authors:
- Jang Hoon LeeJLJang Hoon Lee
- Byung Min ChoiBCByung Min Choi
- Jung Hwa LeeJLJung Hwa Lee
- Kee Hwan YooKYKee Hwan Yoo
- Chang Sung SonCSChang Sung Son
- Joo Won LeeJLJoo Won Lee
- 19 December 2007
- journal article
- Published by S. Karger AG in Neonatology
- Vol. 94 (1) , 16-21
Abstract
Background: Because the major problems of respiratory difficulties in newborn infants are due to cardiopulmonary problems, improving the early detection and referral of newborn infants with cardiovascular problems has been considered one of the primary goals of care in the neonatal intensive care unit. Objective: To evaluate whether rapid plasma B-type natriuretic peptide (BNP) assay could be used as a screening test to detect the cardiovascular problems in newborn infants with respiratory difficulties. Methods: We studied 73 newborn infants ≧34 weeks gestational age presenting with respiratory difficulties during the first few days after birth; they were divided into a cardiovascular problem group (CP group, n = 32) and a noncardiac problem group (NP group, n = 41) according to the presence of cardiovascular problems by clinical and/or echocardiographic studies in newborn infants with respiratory difficulties. Results: On admission, the median (25–75%) BNP concentration of the CP group was significantly higher than that of the NP group [1,038 (578–1,435) vs. 240 (118–388) pg/ml, p < 0.001]. The best cutoff BNP values for differentiating the CP group were 346.0, 421.0, 570.5 and 191.5 pg/ml within 18 h, at 18–36 h, at 36–60 h and after 60 h of life, respectively. Although the plasma BNP measurement was not a single confirmative test, it was found to have a high sensitivity and a high negative predictive value for rapidly ruling out serious cardiovascular problems in neonatal respiratory difficulties. Conclusion: A rapid plasma BNP assay may be useful for detection of cardiovascular problems in newborn infants with respiratory difficulties during the first few days after birth.Keywords
This publication has 19 references indexed in Scilit:
- Longitudinal Changes of Brain-Type Natriuretic Peptide in Preterm NeonatesPediatrics, 2006
- B-type natriuretic peptide in paediatric patients with congenital heart diseaseEuropean Heart Journal, 2006
- Relation of Age, Severity of Illness, and Hemodynamics With Brain Natriuretic Peptide Levels in Patients <20 Years of Age With Heart DiseaseThe American Journal of Cardiology, 2005
- Natriuretic Peptides and Heart Disease in Infants and ChildrenThe Journal of Pediatrics, 2005
- Utility of Rapid B-Type Natriuretic Peptide Assay for Diagnosis of Symptomatic Patent Ductus Arteriosus in Preterm InfantsPediatrics, 2005
- Brain-Type Natriuretic Peptide in the Diagnosis and Management of Persistent Pulmonary Hypertension of the NewbornPediatrics, 2004
- An approach to diagnosis and management of cyanosis and tachypnea in term infantsPediatric Clinics of North America, 2004
- Utility of B-Type Natriuretic Peptide in Differentiating Congestive Heart Failure from Lung Disease in Pediatric Patients with Respiratory DistressPediatric Cardiology, 2004
- Stratification of Pediatric Heart Failure on the Basis of Neurohormonal and Cardiac Autonomic Nervous Activities in Patients With Congenital Heart DiseaseCirculation, 2003
- Quantitative evaluation of the changes in plasma concentrations of cardiac natriuretic peptide before and after transcatheter closure of atrial septal defectActa Paediatrica, 2002